# Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events

> **NCT04519398** · — · UNKNOWN · sponsor: **Grigore T. Popa University of Medicine and Pharmacy** · enrollment: 60 (estimated)

## Conditions studied

- Covid19
- Corona Virus Infection
- Thrombosis
- ARDS
- Thrombophilia
- Thromboses, Intracranial
- Thromboses, Deep Vein
- RAAS

## Interventions

- **GENETIC:** Complete thrombophilic profile testing by multiplex PCR

## Key facts

- **NCT ID:** NCT04519398
- **Lead sponsor:** Grigore T. Popa University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08-18
- **Primary completion:** 2021-02-17
- **Final completion:** 2021-08-18
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04519398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04519398, "Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04519398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*